These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 17124715)

  • 41. On the generation of catalytic antibodies by transition state analogues.
    Barbany M; Gutiérrez-de-Terán H; Sanz F; Villà-Freixa J; Warshel A
    Chembiochem; 2003 Apr; 4(4):277-85. PubMed ID: 12672107
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antibody catalysis: biochemistry, immunology, pathology.
    Gabibov A
    Immunol Lett; 2006 Feb; 103(1):1-2. PubMed ID: 16338008
    [No Abstract]   [Full Text] [Related]  

  • 43. Structure-function analyses of isochorismate-pyruvate lyase from Pseudomonas aeruginosa suggest differing catalytic mechanisms for the two pericyclic reactions of this bifunctional enzyme.
    Luo Q; Olucha J; Lamb AL
    Biochemistry; 2009 Jun; 48(23):5239-45. PubMed ID: 19432488
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Computer-aided design and synthesis of nonpeptidic plasmepsin II and IV inhibitors.
    Luksch T; Chan NS; Brass S; Sotriffer CA; Klebe G; Diederich WE
    ChemMedChem; 2008 Sep; 3(9):1323-36. PubMed ID: 18752222
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Asymmetric Brønsted acid catalysis: catalytic enantioselective synthesis of highly biologically active dihydroquinazolinones.
    Rueping M; Antonchick AP; Sugiono E; Grenader K
    Angew Chem Int Ed Engl; 2009; 48(5):908-10. PubMed ID: 19101974
    [No Abstract]   [Full Text] [Related]  

  • 46. The therapeutic potential for catalytic antibodies: from a concept to a promise.
    Jones LH; Wentworth P
    Mini Rev Med Chem; 2001 Jul; 1(2):125-32. PubMed ID: 12369978
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gold(I)-catalyzed asymmetric cycloisomerization of eneallenes into vinylcyclohexenes.
    Tarselli MA; Chianese AR; Lee SJ; Gagné MR
    Angew Chem Int Ed Engl; 2007; 46(35):6670-3. PubMed ID: 17661298
    [No Abstract]   [Full Text] [Related]  

  • 48. Solvent-enhanced diastereo- and regioselectivity in the Pd(II)-catalyzed synthesis of six- and eight-membered heterocycles via cis-aminopalladation.
    Balázs A; Hetényi A; Szakonyi Z; Sillanpää R; Fülöp F
    Chemistry; 2009 Jul; 15(30):7376-81. PubMed ID: 19551783
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Catalytic antibody-structure and possible applications].
    Amital H; Tur-Caspa I; Hendler I; Shoenfeld Y
    Harefuah; 1995 Mar; 128(5):295-8. PubMed ID: 7744352
    [No Abstract]   [Full Text] [Related]  

  • 50. Stereoelectronic interaction and their effects on conformational preference for 2-substituted methylenecyclohexane: an experimental and theoretical investigation.
    Anizelli PR; Vilcachagua JD; Neto AC; Tormena CF
    J Phys Chem A; 2008 Sep; 112(37):8785-9. PubMed ID: 18714949
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Design of a serine protease-like catalytic triad on an antibody light chain displayed on the yeast cell surface.
    Okochi N; Kato-Murai M; Kadonosono T; Ueda M
    Appl Microbiol Biotechnol; 2007 Dec; 77(3):597-603. PubMed ID: 17899065
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Eucalmaidins A-E, (+)-oleuropeic acid derivatives from the fresh leaves of Eucalyptus maideni.
    Tian LW; Zhang YJ; Wang YF; Lai CC; Yang CR
    J Nat Prod; 2009 Sep; 72(9):1608-11. PubMed ID: 19778089
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Importance of molecular computer modeling in anticancer drug development.
    Geromichalos GD
    J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Iodocyclization reactions for the desymmetrization of cyclohexa-1,4-dienes.
    Butters M; Elliott MC; Hill-Cousins J; Paine JS; Walker JK
    Org Lett; 2007 Aug; 9(18):3635-8. PubMed ID: 17676860
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chiral version of the Burgess reagent and its reactions with oxiranes: application to the formal enantiodivergent synthesis of balanol.
    Sullivan B; Gilmet J; Leisch H; Hudlicky T
    J Nat Prod; 2008 Mar; 71(3):346-50. PubMed ID: 18205317
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Recent trends in library design: 'rational design' revisited.
    Schnur DM
    Curr Opin Drug Discov Devel; 2008 May; 11(3):375-80. PubMed ID: 18428091
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mechanistic analysis of the phosphonate transition-state analogue-derived catalytic and non-catalytic antibody.
    Nishi Y; Yamamoto N; Shimazaki K; Takahashi-Ando N; Kakinuma H; Jialin S; Ruzheinikov SN; Muranova TA; Rice DW; Kajihara Y
    J Biochem; 2007 Oct; 142(4):421-33. PubMed ID: 17981825
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Stereochemical investigation on the construction of poly-functionalized bicyclo[3.3.1]nonenones by successive Michael reactions of 2-cyclohexenones.
    Takagi R; Miwa Y; Nerio T; Inoue Y; Matsumura S; Ohkata K
    Org Biomol Chem; 2007 Jan; 5(2):286-300. PubMed ID: 17205172
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antioxidant activity of the anti-inflammatory compound ebselen: a reversible cyclization pathway via selenenic and seleninic acid intermediates.
    Sarma BK; Mugesh G
    Chemistry; 2008; 14(34):10603-14. PubMed ID: 18932179
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Alternating copolymerization of epoxides and cyclic anhydrides: an improved route to aliphatic polyesters.
    Jeske RC; DiCiccio AM; Coates GW
    J Am Chem Soc; 2007 Sep; 129(37):11330-1. PubMed ID: 17722928
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.